Elgodipine ( —— )

产品货号. M36162 CAS No. 119413-55-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Elgodipine
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
产品描述

Elgodipine significantly reduced the incidence and severity of exercise-induced angina pectoris systemically and was able to inhibit vascular smooth muscle proliferation through a mechanism independent of the expression of the transcription factors c-fos and c-jun. The Elgodipine-induced inhibition was voltage-dependent. Elgodipine is a potential compound for the treatment of angina pectoris.
体外实验

——
体内实验

——
同义词

——
通路

Others
靶点

Other Targets
受体

Others
研究领域

——
适应症

——

CAS Number

119413-55-7
分子量

524.58
分子式

C29H33FN2O6
纯度

>98% (HPLC)
溶解度

——
SMILES

C(OCCN(CC1=CC=C(F)C=C1)C)(=O)C=2C(C(C(OC(C)C)=O)=C(C)NC2C)C3=C4C(=CC=C3)OCO4
化学全称

——

计算器

产品手册

关联产品

BMS986260

BMS-986260 是一种选择性、口服生物可利用的 TGFβR1 抑制剂 (IC50 = 1.6 nM)。 BMS-986260 在多种 TGFβ 依赖性细胞测定中表现出功能活性、优异的激酶组选择性、良好的药代动力学特性以及与抗 PD-1 抗体联合在小鼠结直肠癌 (CRC) 模型中的体内疗效。
CALP1

Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site; produces CaM-dependent activation of phosphodiesterase. Also binds to cytoplasmic sites on other Ca2+ channels, including NMDA and HIV-1 gp120-activated channels, inhibiting Ca2+-mediated cytotoxicity and apoptosis (IC50 = 52 μM). Shown to protect pancreatic acinar cells from gossypol induced necrosis. Inhibits VLA-5-mediated adhesion of mast cells to fibronectin in vitro and attenuates inflammatory cell influx in guinea pig lung in vivo.
[Lys6] Leu-Enkephali...

[Lys6] Leu-Enkephalin